SubHero Banner
Text

April 2022

Core topics in this month’s edition include:

  • Aduhelm (aducanumab) – drug update
  • Alymsys (bevacizumab-maly) – new biosimilar approval 
  • COVID-19 Vaccines – drug update
  • Sotrovimab – emergency use authorization revision

Download PDF

Text